Viemed Healthcare reports Q1 2026 revenue of $75.4M, raises full-year guidance

VIEMED HEALTHCARE, INC.

2026-Q1 EPS reported $0.06 revenue$75,414,000

Net revenues increased 28% to $75.4 million for Q1 2026, up from $59.1 million in Q1 2025.
Adjusted EBITDA for Q1 2026 was $14.3 million, a 12% increase versus the prior year quarter.
Company repurchased 150,000 common shares at an average price of $9.29 per share during Q1.
Ventilator patient count reached 12,089; PAP therapy patient count grew 57% to 35,938 as of March 31.
Full-year 2026 net revenue guidance raised to $312–$320 million from prior $310–$320 million.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

VIEMED HEALTHCARE, INC. reported the three months ended March 31, 2026 results: revenue $75.4 million, net income $2.6 million, EPS $0.06 per diluted share. Guidance raised.

Period: the three months ended March 31, 2026
Revenue: $75.4 million
Net income: $2.6 million
EPS: $0.06 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

and updated guidance for the full year ending December 31, 2026. Operational highlights (all dollar amounts are USD): • Net revenues for the quarter ended March 31, 2026 were $75.4 million, representing an increase of $16.3 million, or 28%, over net revenues reported for the comparable quarter ended March 31, 2025. • Net income attributable to Viemed for the

View on SEC.gov

Browse all earnings releases →

VIEMED HEALTHCARE, INC. filing history →

Source: SEC EDGAR

accession 0001729149-26-000028

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.